The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attr...
In today’s highly competitive and rapidly evolving business landscape, having access to accurate and actionable market intelligence has become more important than ever. Organizations across indus...